These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

79 related items for PubMed ID: 6155211

  • 1. Methotrexate-citrovorum factor used alone and in combination chemotherapy for advanced hypernephromas.
    Baumgartner G, Heinz R, Arbes H, Lenzhofer R, Pridun N, Schüller J.
    Cancer Treat Rep; 1980 Jan; 64(1):41-6. PubMed ID: 6155211
    [Abstract] [Full Text] [Related]

  • 2. [Methotrexate citrovorum factor therapy in advanced hypernephromas (author's transl)].
    Baumgartner G, Heinz R, Linemayr G.
    Wien Klin Wochenschr; 1980 Aug 01; 92(15):526-30. PubMed ID: 6159741
    [Abstract] [Full Text] [Related]

  • 3. Methotrexate as a single agent and in combination chemotherapy for the treatment of non-Hodgkin's lymphoma of unfavorable histology.
    Canellos GP, Skarin AT, Rosenthal DS, Moloney WC, Frei E.
    Cancer Treat Rep; 1981 Aug 01; 65 Suppl 1():125-9. PubMed ID: 6173118
    [Abstract] [Full Text] [Related]

  • 4. High-dose methotrexate with citrovorum factor in osteogenic sarcoma--progress report II.
    Jaffe N, Frei E, Traggis D, Cassady JR, Watts H, Filler RM.
    Cancer Treat Rep; 1977 Jul 01; 61(4):675-9. PubMed ID: 301780
    [Abstract] [Full Text] [Related]

  • 5. [High dose methotrexate with CF rescue therapy in patients with head and neck cancer].
    Inuyama Y, Taketa C, Hiroto I, Fujii M, Takaoka T, Tanaka J, Matsuura S, Satake B, Takeoda S, Nishijima W.
    Gan To Kagaku Ryoho; 1984 Sep 01; 11(9):1823-31. PubMed ID: 6332576
    [Abstract] [Full Text] [Related]

  • 6. [Moderate dose methotrexate with citrovorum factor rescue therapy in the treatment of head and neck cancer].
    Inuyama Y, Hiroto I, Taketa C, Horiuchi M, Mashino S, Fujii M, Matsuura S, Satake B, Takeoda S, Nishijima W, Okuda M, Sakaguchi K, Tanigaito Y, Imakirei M, Konno T, Hirokawa T, Takada K, Ono I, Saitoh H, Takemiya S, Shimada F, Omura K, Miyake H, Fujii K, Kawabe Y, Kondoh T, Komiyama S, Yanagida T, Matsumura Y, Hirano M, Araki S.
    Gan To Kagaku Ryoho; 1982 Dec 01; 9(12):2193-200. PubMed ID: 6764099
    [Abstract] [Full Text] [Related]

  • 7. Combination chemotherapy for advanced non-Hodgkin's lymphomas other than diffuse histiocytic or undifferentiated histologies.
    Anderson KC, Skarin AT, Rosenthal DS, MacIntyre JM, Pinkus GS, Case DC, Leonard RC, Canellos GP.
    Cancer Treat Rep; 1984 Nov 01; 68(11):1343-50. PubMed ID: 6209007
    [Abstract] [Full Text] [Related]

  • 8. High-dose methotrexate with leucovorin rescue, vinblastine, and bleomycin with or without tamoxifen in metastatic renal cell carcinoma.
    Bell DR, Aroney RS, Fisher RJ, Levi JA.
    Cancer Treat Rep; 1984 Apr 01; 68(4):587-90. PubMed ID: 6201268
    [Abstract] [Full Text] [Related]

  • 9. Combinations of methotrexate (COP or CHOP) in the treatment of previously untreated and treated lymphomas.
    Gomez GA, Stutzman L, Moayeri H, Shimaoka K, Plager J, Han T, Naeher C, Henderson E.
    Cancer Treat Rep; 1982 Jan 01; 66(1):43-7. PubMed ID: 6975659
    [Abstract] [Full Text] [Related]

  • 10. Prolonged disease-free survival in advanced breast cancer treated with "super-CMF" adriamycin: an alternating regimen employing high-dose methotrexate with citrovorum factor rescue.
    Henderson IC, Gelman R, Canellos GP, Frei E.
    Cancer Treat Rep; 1981 Jan 01; 65 Suppl 1():67-75. PubMed ID: 6976832
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Phase II clinical trial with high-dose methotrexate therapy and citrovorum factor rescue.
    Isacoff WH, Eilber F, Tabbarah H, Klein P, Dollinger M, Lemkin S, Sheehy P, Cone L, Rosenbloom B, Sieger L, Block JB.
    Cancer Treat Rep; 1978 Sep 01; 62(9):1295-304. PubMed ID: 356984
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Phase I trial of methotrexate-albumin in a weekly intravenous bolus regimen in cancer patients. Phase I Study Group of the Association for Medical Oncology of the German Cancer Society.
    Hartung G, Stehle G, Sinn H, Wunder A, Schrenk HH, Heeger S, Kränzle M, Edler L, Frei E, Fiebig HH, Heene DL, Maier-Borst W, Queisser W.
    Clin Cancer Res; 1999 Apr 01; 5(4):753-9. PubMed ID: 10213209
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Adjuvant chemotherapy for invasive urothelial cancer: experience with a methotrexate, vincristine, cisplatin, cyclophosphamide, adriamycin and bleomycin (MVP-CAB) regimen: a preliminary report.
    Gohji K, Higuchi A, Maruyama S, Minayoshi K, Fujii A, Itoh N, Hasunuma Y, Tanaka H, Izumi T.
    Jpn J Clin Oncol; 1993 Oct 01; 23(5):291-8. PubMed ID: 7693990
    [Abstract] [Full Text] [Related]

  • 19. High-dose methotrexate with leucovorin rescue in ovarian cancer: a phase II study.
    Parker LM, Griffiths CT, Yankee RA, Knapp RC, Canellos GP.
    Cancer Treat Rep; 1979 Feb 01; 63(2):275-9. PubMed ID: 312692
    [Abstract] [Full Text] [Related]

  • 20. Selected applications of methotrexate alone and in combination in osteosarcoma.
    Pratt CB.
    Cancer Treat Rep; 1981 Feb 01; 65 Suppl 1():107-11. PubMed ID: 6976828
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.